心血管病学进展
心血管病學進展
심혈관병학진전
ADVANCES IN CARDIOVASCULAR DISEASES
2015年
4期
451-454
,共4页
余香(综述)%肖骅(审校)
餘香(綜述)%肖驊(審校)
여향(종술)%초화(심교)
心房颤动%导管消融术%华法林%利伐沙班
心房顫動%導管消融術%華法林%利伐沙班
심방전동%도관소융술%화법림%리벌사반
atrial fibrillation%catheter ablation%warfarin%rivaroxaban
新型抗凝药利伐沙班在非瓣膜性心房颤动患者预防脑卒中或全身性栓塞已有充分的临床应用证据,但其在心房颤动导管消融围手术期的用药策略尚无统一意见。通过对相关临床研究进行分类分析,以期为利伐沙班在心房颤动导管消融围手术期的临床合理应用策略提供参考。
新型抗凝藥利伐沙班在非瓣膜性心房顫動患者預防腦卒中或全身性栓塞已有充分的臨床應用證據,但其在心房顫動導管消融圍手術期的用藥策略尚無統一意見。通過對相關臨床研究進行分類分析,以期為利伐沙班在心房顫動導管消融圍手術期的臨床閤理應用策略提供參攷。
신형항응약리벌사반재비판막성심방전동환자예방뇌졸중혹전신성전새이유충분적림상응용증거,단기재심방전동도관소융위수술기적용약책략상무통일의견。통과대상관림상연구진행분류분석,이기위리벌사반재심방전동도관소융위수술기적림상합리응용책략제공삼고。
Rivaroxaban was approved for the prevention of stroke or embolism in patients with nonvalvular atrial fibrillation ( AF ) . However, There is no unified opinion of periprocedural anticoagulation strategies for the patients undergoing AF ablation.This article reviews the studies of periprocedural management of rivaroxaban in patients undergoing AF ablation,to provide evidence for clinical reasonable appli-cation strategy of rivaroxaban.